NDC 0053-0190-19
HEMGENIX
etranacogene dezaparvovec · KIT
Hemgenix is a gene therapy used to treat adults with severe hemophilia B by delivering a functional gene to help the body produce clotting factor IX. It is administered as a one-time infusion to reduce or eliminate the need for regular blood clotting factor treatments.
Key Facts
- Brand Name
- HEMGENIX
- Generic Name
- etranacogene dezaparvovec
- NDC Code (Package)
0053-0190-19- NDC Code (Product)
0053-0190- Manufacturer
- CSL Behring
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125772
- Marketing Start
- 11/22/2022
Recall History
No Recall HistoryView Full Drug Page
HEMGENIX — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.